[
    [
        {
            "time": "",
            "original_text": "错失新冠被抛售？复星出售亚能生物股份，可能还是要想‘资本局’ 减持股份数量",
            "features": {
                "keywords": [
                    "复星",
                    "亚能生物",
                    "新冠",
                    "抛售",
                    "资本局",
                    "减持"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "错失新冠被抛售？复星出售亚能生物股份，可能还是要想‘资本局’ 减持股份数量",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "赛诺菲退出mRNA新冠疫苗研究 沃森生物静待三期临床结果",
            "features": {
                "keywords": [
                    "赛诺菲",
                    "mRNA",
                    "新冠疫苗",
                    "沃森生物",
                    "三期临床"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "赛诺菲退出mRNA新冠疫苗研究 沃森生物静待三期临床结果",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "连卖4家子公司‘瘦身’ 大刀阔斧革新诊断业务 复星医药在下什么棋？",
            "features": {
                "keywords": [
                    "复星医药",
                    "子公司",
                    "瘦身",
                    "革新",
                    "诊断业务"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "诊断"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "连卖4家子公司‘瘦身’ 大刀阔斧革新诊断业务 复星医药在下什么棋？",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "复星医药年内四次出售资产，将布局新赛道加速业务转型 资产异常",
            "features": {
                "keywords": [
                    "复星医药",
                    "资产出售",
                    "新赛道",
                    "业务转型"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "资产配置"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药年内四次出售资产，将布局新赛道加速业务转型 资产异常",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]